Jason A. Efstathiou

Also affiliated with Massachusetts General Hospital, Mass General Brigham

MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

5.7Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.08.034

Top 5%

4.7DataRank

Top 5%141 citations

E.S. Paulson, Brian J. Davis, Daniel E. Spratt, Todd M. Morgan, David P. Dearnaley +20 more

Papers

Driven by 29 papers — median percentile 61. Top paper: “NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer”.

NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.08.034

Top 5%

4.7DataRank

Top 5%141 citations

E.S. Paulson, Brian J. Davis, Daniel E. Spratt, Todd M. Morgan, David P. Dearnaley +20 more

A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study

European Urology(2023)10.1016/j.eururo.2023.01.017

N/A

2.1DataRank · unranked

57 citations

Michael A. O’Donnell, Jason A. Efstathiou, Marianna Zahurak, Gary L. Rosner, Jeff Smith +36 more

Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.12.035

N/A

1.1DataRank · unranked

51 citations

Huei–Chung Huang, Daniel E. Spratt, Elai Davicioni, Howard M. Sandler, William U. Shipley +17 more

Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.01.035

N/A

0.777DataRank · unranked

18 citations

Stephanie L. Pugh, Ronald C. Eldridge, Katherine A. Yeager, Qi Zhang, W. Robert Lee +15 more

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer

Journal of Clinical Oncology(2025)10.1200/jco-25-01608

N/A

0.674DataRank · unranked

20 citations

Matthew D. Galsky, Nazlı Dizman, David H. Aggen, Neeraj Agarwal, Hikmat Al‐Ahmadie +39 more

Transcriptome profiling of NRG Oncology/RTOG 9601: Validation of a prognostic genomic classifier in salvage radiotherapy prostate cancer patients from a prospective randomized trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.276

Top 39%

0.489DataRank

Top 39%11 citations

Howard M. Sandler, Huei–Chung Huang, Jeffry Simko, Elai Davicioni, Paul L. Nguyen +15 more

Longitudinal Analysis of Bladder Cancer-Specific Mortality Trends in the United States

Bladder Cancer(2023)10.3233/blc-230062

Top 43%

0.439DataRank

Top 43%7 citations

David Qi, Anushka Ghosh, Saveli Goldberg, Fumiko Chino, Jason A. Efstathiou +2 more

Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.09.043

N/A

0.330DataRank · unranked

8 citations

Beow Y. Yeap, Jeff M. Michalski, Nora Horick, Anthony L. Zietman, John P. Christodouleas +15 more

INNOVATE (NRG-GU008): A randomized phase III trial of salvage radiotherapy and androgen deprivation therapy (ADT) with/without abiraterone and apalutamide for patients with node-positive prostate cancer after radical prostatectomy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.tps179

N/A

0.292DataRank · unranked

6 citations

Theodore Karrison, C.A. Lawton, William A. Hall, Hala T. Borno, Mihaela Roşu +8 more

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

European Urology Oncology(2025)10.1016/j.euo.2025.04.009

N/A

0.214DataRank · unranked

3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Jeffry Simko +17 more

EA8185: Phase 2 study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node-positive urothelial carcinoma (INSPIRE), an ECOG-ACRIN/NRG collaboration.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps4617

N/A

0DataRank · unranked

4 citations

Se Eun Kim, Abhishek A. Solanki, David T. Miyamoto, David J. DeGraff, Jennifer Wei Zou +8 more

EA8185: Phase 2 study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node positive urothelial carcinoma (INSPIRE), an ECOG-ACRIN/NRG collaboration.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.tps594

N/A

0DataRank · unranked

0 citations

Se Eun Kim, Abhishek A. Solanki, David T. Miyamoto, David J. DeGraff, Jennifer Wei Zou +8 more

Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans

European Urology Open Science(2021)10.1016/j.euros.2021.05.009

N/A

0DataRank · unranked

35 citations

Daniel Cherry, P.T. Courtney, Vinit Nalawade, Nikhil V. Kotha, Paul Riviere +6 more

Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0792

N/A

0DataRank · unranked

17 citations

Yuzhen Zhou, Keisuke Otani, Michael Drumm, Yukako Otani, Shulin Wu +17 more

Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer

Urologic Oncology Seminars and Original Investigations(2023)10.1016/j.urolonc.2022.12.011

N/A

0DataRank · unranked

9 citations

Yuan Liu, Abhishek A. Solanki, Brian C. Baumann, Jason A. Efstathiou, Ashesh B. Jani +4 more

Basal-luminal subtyping of localized high-risk prostate cancer and benefit of adding docetaxel to definitive radiotherapy with androgen suppression in the NRG Oncology/RTOG 0521 phase III trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5094

N/A

0DataRank · unranked

3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Felix Y. Feng +15 more

Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials

European Urology Oncology(2024)10.1016/j.euo.2024.10.017

N/A

0DataRank · unranked

2 citations

Paul L. Nguyen, James A. Proudfoot, Yang Liu, Alan Dal Pra, Daniel E. Spratt +16 more

Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712

European Urology Oncology(2024)10.1016/j.euo.2024.03.015

N/A

0DataRank · unranked

2 citations

Sophia C. Kamran, Amol C. Shetty, Philip Sutera, Yang Song, Soha Bazyar +29 more

Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials

Annals of Oncology(2025)10.1016/j.annonc.2025.01.017

N/A

0DataRank · unranked

16 citations

Pirus Ghadjar, Hyunnam Ryu, J.A. Proudfoot, Stefanie Hayoz, J.M. Michalski +28 more

Combination Metastasis-Targeted External Beam Radiation Therapy With 177Lu-PSMA-617 in Patients With Advanced Castration-Resistant Prostate Cancer

Practical Radiation Oncology(2025)10.1016/j.prro.2025.03.010

N/A

0DataRank · unranked

5 citations

Isabella R. Pompa, Veronica Haberman, Bashar Kako, Richard J. Lee, Philip J. Saylor +10 more

Predictive Model of Acute Rectal Toxicity in Prostate Cancer Treated With Radiotherapy

JCO Clinical Cancer Informatics(2025)10.1200/cci-24-00252

N/A

0DataRank · unranked

2 citations

Beow Y. Yeap, Hoyeon Lee, Z. Soetan, M. Moteabbed, Stacey Muise +12 more

A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-3327

N/A

0DataRank · unranked

2 citations

Naoto Tokuyama, Kamal Hammouda, Tilak Pathak, Tuomas Mirtti, Pingfu Fu +15 more

Impact of Community-Based Clinical Breast Examinations in Botswana

JCO Global Oncology(2021)10.1200/go.20.00231

N/A

0DataRank · unranked

7 citations

Brighid Malone, Onica Lekuntwane, Jason A. Efstathiou, Virginia Letsatsi, Shekinah N.C. Elmore +4 more

Proceedings of the 2024 National Association for Proton Therapy, Proton Collaborative Group, and Particle Therapy Co-operative Group—North America Proton Therapy Research Forum: Refining Particle Therapy Trial Design and Identifying High-need Areas for Continued Investigation

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.06.3880

N/A

0DataRank · unranked

0 citations

Anita Mahajan, Michael G. Barron, Jeffrey D. Bradley, Michael D. Chuong, Curtiland Deville +13 more

EA8185: Phase II study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node-positive urothelial carcinoma (INSPIRE), ECOG-ACRIN/nrg collaboration.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.tps500

N/A

0DataRank · unranked

4 citations

Se Eun Kim, Abhishek A. Solanki, David T. Miyamoto, David J. DeGraff, Jennifer Wei Zou +8 more

EA8185: Phase 2 study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node positive urothelial carcinoma (INSPIRE)—An ECOG-ACRIN and NRG Collaboration.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps4590

N/A

0DataRank · unranked

0 citations

Se Eun Kim, Abhishek A. Solanki, David T. Miyamoto, David J. DeGraff, Jennifer Wei Zou +8 more

Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)

European Urology(2022)10.1016/j.eururo.2022.07.011

N/A

0DataRank · unranked

63 citations

Fang‐I Chu, Howard M. Sandler, Felix Y. Feng, Jason A. Efstathiou, Christopher U. Jones +37 more

Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2021.03.007

N/A

0DataRank · unranked

22 citations

Yuan Liu, Matthew I. Milowsky, Jason A. Efstathiou, Ashesh B. Jani, Benjamin W. Fischer‐Valuck +2 more

Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.42378

N/A

0DataRank · unranked

13 citations

Jennifer Moughan, David T. Miyamoto, Jeff Simko, William U. Shipley, Phillip J. Gray +20 more

Jason A. Efstathiou

Indexed papers

Top data-sharing exemplar

Papers